High-tech glasses developed at Washington University School of Medicine in St. Louis may help surgeons visualize cancer cells, which glow blue when viewed through the eyewear.
The wearable technology, so new it’s yet unnamed, was used during surgery for the first time today at Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.
Cancer cells are notoriously difficult to see, even under high-powered magnification. The glasses are designed to make it easier for surgeons to distinguish cancer cells from healthy cells, helping to ensure that no stray tumor cells are left behind during surgery.
“We’re in the early stages of this technology, and more development and testing will be done, but we’re certainly encouraged by the potential benefits to patients,” said breast surgeon Julie Margenthaler, MD, an associate professor of surgery at Washington University, who performed today’s operation. “Imagine what it would mean if these glasses eliminated the need for follow-up surgery and the associated pain, inconvenience and anxiety.”
Current standard of care requires surgeons to remove the tumor and some neighboring tissue that may or may not include cancer cells. The samples are sent to a pathology lab and viewed under a microscope. If cancer cells are found in neighboring tissue, a second surgery often is recommended to remove additional tissue that also is checked for the presence of cancer.
The glasses could reduce the need for additional surgical procedures and subsequent stress on patients, as well as time and expense.
Margenthaler said about 20 to 25 percent of breast cancer patients who have lumps removed require a second surgery because current technology doesn’t adequately show the extent of the disease during the first operation.
“Our hope is that this new technology will reduce or ideally eliminate the need for a second surgery,” she said.
The technology, developed by a team led by Samuel Achilefu, PhD, professor of radiology and biomedical engineering at Washington University, incorporates custom video technology, a head-mounted display and a targeted molecular agent that attaches to cancer cells, making them glow when viewed with the glasses.
The Latest on: Seeing cancer
via Google News
The Latest on: Seeing cancer
- See how this Gainesville woman turned her battle with cancer into hope for otherson December 8, 2021 at 10:38 am
Nicole Miller launched Blossoming Butterfly to support others battling cancer through financial aid, research and self-care.
- Alabama’s Hannah Brown reveals family tragedy, cancer scare in new memoiron December 8, 2021 at 10:34 am
The former "Bachelorette" star doesn't hold back in "God Bless This Mess," detailing events such as the murder of three relatives in her home state.
- Zen Scott Cannon’s life sheds light on pediatric brain canceron December 8, 2021 at 9:54 am
The news of the sudden passing of Nick Cannon’s youngest son, 5-month-old Zen Scott Cannon, has sent shockwaves through the media world.
- City of Hope to buy Cancer Treatment Centers of America for $390 millionon December 8, 2021 at 9:30 am
City of Hope, a California-based not-for-profit cancer research organization, is buying the for-profit Cancer Treatment Centers of America chain for $390 million. Why it matters: The merger would ...
- TROP2-Directed ADC Promising in Advanced Triple-Negative Breast Canceron December 8, 2021 at 9:01 am
The investigational agent datopotamab deruxtecan (Dato-DXd) offered antitumor activity with a manageable safety profile in patients with previously treated metastatic triple-negative breast cancer ...
- As a Cancer Survivor, the COVID-19 Omicron Variant Makes Me Want to Screamon December 8, 2021 at 8:03 am
Each time a new COVID-19 variant takes the world by storm, cancer survivors struggle to cope with the resulting exhaustion and fear, one survivor explains.
- Report: Some Laredoans 100% more likely to get cancer than rest of U.S.on December 8, 2021 at 6:26 am
Following the release of a report from ProPublica — a newsroom aiming to produce investigative journalism in the public interest — which indicated these particular risks to Laredo residents, District ...
- Final Analysis of PALLAS Shows No Benefit With Palbociclib Plus Endocrine Therapy in Early Breast Canceron December 8, 2021 at 6:00 am
The following article features coverage from the 2021 San Antonio Breast Cancer Symposium. Click here to read more of Cancer Therapy Advisor’s conference coverage. The addition of palbociclib to ...
- Oncology doctors say Build Back Better Act will slash cancer care funding; ad 'half-true'on December 8, 2021 at 4:18 am
An advertisement from the Community Oncology Alliance, part of a $1.6 million campaign running on radio and in print, attacks a proposal in the Democratic-backed Build Back Better package. It's only ...
- Oncology doctors say the build back better act will slash cancer care funding — a skewed argumenton December 8, 2021 at 2:43 am
An independent analysis shows that payments for cancer care will be slashed by close to 45% causing cancer clinics to close and massively raising your healthcare costs” ...
via Bing News